login
Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
Circadian Technologies’ Investigative Cancer Drug Receives FDA Nod for Clinical Trials
The company’s chief executive Robert Klupacs said that they are finalizing clinical trial sites in the United States and will initiate the clinical trials for the drug, known as VGX-100, by the end of this year with the results expected to be available in the second half of 2012.
“We are well advanced in finalising clinical trial sites in the USA and expect clinical trials to commence before the end of 2011 with results becoming available from the study in the second half of 2012”, he said, adding that the Phase I trial will involve treating various types of cancer among patients who are in the late stage.
Source-Medindia
|
|
More News on: Drug Toxicity, Clinical Trials, Cancer and Homeopathy, Clinical Trials - The Past and The Future , Clinical Trials - Different Phases of the trial , Signature Drug Toxicity, Cancer Facts, Cancer, Tattoos A Body Art, Drugs Banned in India
 Comment & Contribute
|
- Health News Index
 | Quiz on Cancer Looking for information on cancer? Go through medindia's Cancer quiz. 
|
- News Quick Links
 |
Cancer
Complete Medindia Resources
|
| News Categories: |
| » | Report: A Lot of Americans Have No Access to Health Care |
| » | Greece Faces Humanitarian Crisis as Health Care Access Declines in EU, Doctors Group Warns |
| » | HCCI Report Says Rising Prices for Care Responsible for Increased Healthcare Costs for Privately Insured Americans |
| » | Treatment in ED is Based on Children's Insurance Status |
| » | US Spends Most on Healthcare Without Providing Superior Care |
| More Insurance News | |
|
